Nanomol Technologies present at Clinam 2018 Summit

The CLINAM Summit is a globally unique event that brings together all stakeholders in nanomedicine, targeted medicine and precision medicine. Our CEO Santi Sala has participated into the session Presentations on Nanoparticles – Analytics, Methods and Technologies by presenting the work Technology platform for the production of lipid-based nanovesicles as new nanomedicines. By this presentation he has described latest developments related to our projects Nano-Nafres which belongs to the RIS3CAT community “Technologies applied to health”, and Horizon 2020 project “Smart-4-Fabry” – Smart multifunctional GLA-nanoformulation for Fabry disease. He has presented as well our cGMP contract analysis services on micro and nanoparticles characterization techniques.